Katerina Veverova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.
Journal: Nature aging
Published: January 05, 2026
A combined artificial intelligence-wet lab approach identifies a pivotal role of the NAD+-mitophagy axis on aging and neurodegeneration.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 15, 2025
Willingness and barriers to blood-based biomarker testing of Alzheimer's disease in the general population in the Czech Republic.
Journal: Alzheimer's research & therapy
Published: December 08, 2025
Semantic verbal fluency assessment using computational analysis in the Czech language.
Journal: Applied neuropsychology. Adult
Published: September 24, 2025
Specific Lipid Peroxidation Products in Erythrocytes and Their Relationship to the Pathogenesis of Alzheimer's Disease.
Journal: Journal of cellular and molecular medicine
Published: September 09, 2025
Concordance between amyloid PET and CSF biomarkers in clinical setting: a cross-platform comparison and in-depth analysis of discordant cases.
Journal: Scientific reports
Published: June 27, 2025
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 10, 2025
Associations of KLOTHO-VS heterozygosity and α-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.
Journal: Journal of Alzheimer's disease : JAD
Published: March 20, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 23, 2024
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment.
Journal: Nature communications
Published: July 12, 2024
CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis.
Journal: Alzheimer's research & therapy
Published: July 05, 2024
Distinctive autophagy/mitophagy biomarker profiles in frontotemporal lobar degeneration and Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: June 20, 2024
Last Updated: 09/26/2026